Bot Chart, page-14220

What are expecting from the update that we do not already know? thought BoT is gearing up for sales, establishing channels, marketing and campaigns, roadshows, workshops blah blah to drive revenue from Q4.

Other than reiterating progress of commercialization process and patient experience program, am not expecting anything more than an update what was said in the last quarterly report. Obviously good progress and sound management will be positive to the market....but the upside will come Q1 FY25 and Q2 Fy25 once these initial numbers and uptake comes through and also based on revenue an EBITDA figures that mgt commit too in their forecast will also be telling against analyst expectations.